[PEARW] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PEARW] Pear Therapeutics, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 85.88%
YoY- -777.65%
Quarter Report
PEARW's Result
PEARW's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 CAGR
Revenue 2,749 0 -
PBT -23,859 1,915 -1345.90%
Tax -10,882 0 -
NP -12,977 1,915 -777.65%
Tax Rate - 0.00% -
Total Cost 15,726 -1,915 -921.20%
Ratio Analysis
31/03/22 31/03/21 CAGR
NP Margin -472.06 0.00 -
Per Share
31/03/22 31/03/21 CAGR
EPS -0.09 0.07 -228.57%
EPS Diluted -0.09 0.29 -131.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.